Tacrolimus Aggravated Tube Feeding Syndrome with Acute Renal Failure in a Pediatric Liver Transplant Recipient

Tacrolimus Aggravated Tube Feeding Syndrome with Acute Renal Failure in a Pediatric Liver Transplant Recipient

Acute renal failure can be caused by calcineurin inhibitors (CNIs), due to arteriolopathy and altered tubular function. Within this context, we present the case of a 14-month-old liver transplant recipient who suffered an acute polyuric renal failure during a short episode of hypercaloric feeding. I...

Full description

Bibliographic Details
Main Authors:	R. Kula, M. Melter, J. Kunkel, C. Dörfler, S. Alikadic, B. Knoppke, R. Zant
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Case Reports in Transplantation
Online Access:	http://dx.doi.org/10.1155/2017/7345680

Similar Items

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010-09-01)

Massive pleural effusion in a renal transplant recipient on tacrolimus
by: L S Nayagam, et al.
Published: (2014-01-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Role of fludrocortisone in the management of tacrolimus-induced hyperkalemia in a renal transplant recipient
by: V Sivakumar, et al.
Published: (2014-01-01)

Tacrolimus as a rare cause of pericardial effusion in a renal transplant recipient
by: Rohini Prashar, et al.
Published: (2017-01-01)

Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients
by: Saeed Alqahtani, et al.
Published: (2021-01-01)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012-09-01)

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
by: Pasternak AL, et al.
Published: (2021-03-01)

Comparative Study of the Cellular Pharmacodynamics of Tacrolimus in Renal Transplant Recipients Treated with and without Basiliximab
by: Kentaro Sugiyama Ph.D., et al.
Published: (2012-03-01)

Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
by: Hanna Michael G, et al.
Published: (2006-03-01)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

Blood Profiles of Gut Bacterial Tacrolimus Metabolite in Kidney Transplant Recipients
by: Yukuang Guo, MS, et al.
Published: (2020-10-01)

Tacrolimus-Induced Hyponatremia in Lung Transplant Recipients: A Case Series
by: Paul N. Banks, MA, et al.
Published: (2018-04-01)

Treatment of Acute Tacrolimus Toxicity with Phenytoin in Solid Organ Transplant Recipients
by: Arin S. Jantz, et al.
Published: (2013-01-01)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01)

Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)

The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients
by: Sireen Shilbayeh, et al.
Published: (2013-01-01)

Once-Daily Tacrolimus Extended-Release Formulation: 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients
by: Lars Pape, et al.
Published: (2011-01-01)

HEMOFILTRATION AND COUPLED PLASMA FILTRATION ADSORPTION IMPACT ON TACROLIMUS BLOOD CONCENTRATION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)

Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.
by: Ellen Kreijveld, et al.
Published: (2008-01-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?
by: Simon Ball
Published: (2017-11-01)

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
by: Seung Seok Han, et al.
Published: (2016-01-01)

Use of pharmacogenomics in pediatric renal transplant recipients
by: Mara eMedeiros, et al.
Published: (2015-02-01)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
by: S Dashti-Khavidaki, et al.
Published: (2016-07-01)

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
by: Ammon Handisurya, et al.
Published: (2016-01-01)

The Effect of Cyclosporine、Tacrolimus and Sirolimus on the Concentration of Mycophenolic Acid in Renal Transplant Recipients Taking Mycophenolate Mofetil
by: Chih-Yuan Lee, et al.
Published: (2007)

Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017-03-01)

Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient
by: Samuel Chan, et al.
Published: (2017-01-01)

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
by: Kinga Krzyżowska, et al.
Published: (2018-01-01)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
by: Sebastian C. B. Bremer, et al.
Published: (2018-11-01)

Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients.
by: Nynke M Kannegieter, et al.
Published: (2018-01-01)

Features of the immune system response in pediatric renal transplant recipients
by: V.P. Zakordonets, et al.
Published: (2019-10-01)

Correlation between insulin-like growth factor 1 levels and tacrolimus dose in pediatric liver recipients
by: R. M. Kurabekova, et al.
Published: (2021-07-01)

Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
by: Dagmara Szypulska-Koziarska, et al.
Published: (2021-07-01)

Cystatin C and renal function in pediatric kidney transplant recipients
by: M.C.P. Franco, et al.
Published: (2009-12-01)

Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients
by: Michele Pinon, et al.
Published: (2021-01-01)

Resolution of Neurotoxicity and β-Cell Toxicity in an Islet Transplant Recipient following Substitution of Tacrolimus with MMF
by: Tatiana Froud, et al.
Published: (2006-08-01)

Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
by: Ashok Thorat, et al.
Published: (2014-01-01)

Cannot write session to /tmp/vufind_sessions/sess_h7vst4hn3nt07ngvfeb56av570